Enefexine
| Clinical data | |
|---|---|
| Other names | 4-(4-Ethylphenyl)piperidine |
| Drug class | Antidepressant |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H19N |
| Molar mass | 189.302 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Enefexine (INN), also known as 4-(4-ethylphenyl)piperidine, is a drug of the phenylpiperidine group which is described as an antidepressant but was never marketed. It was first described in the literature by 1983. The drug was developed by Ciba-Geigy.